loadpatents
Patent applications and USPTO patent grants for TEOBALD; Barry John.The latest application filed is for "itaconic acid derivatives and uses thereof intreating an inflammatory disease or a disease associated with an undesirable immune response".
Patent | Date |
---|---|
Itaconic Acid Derivatives And Uses Thereof Intreating An Inflammatory Disease Or A Disease Associated With An Undesirable Immune Response App 20220265595 - COOKE; Michael Liam ;   et al. | 2022-08-25 |
Pharmaceutical compounds Grant 11,352,342 - Brown , et al. June 7, 2 | 2022-06-07 |
Pharmaceutical compounds Grant 11,319,312 - Brown , et al. May 3, 2 | 2022-05-03 |
Muscarinic agonists Grant 11,254,656 - Brown , et al. February 22, 2 | 2022-02-22 |
Bicyclic Aza Compounds As Muscarinic M1 And/or M4 Receptor Agonists App 20210387969 - Brown; Giles Albert ;   et al. | 2021-12-16 |
Pyrazole Derivatives As H4 Antagonist Compounds App 20210300906 - Brown; Giles Albert ;   et al. | 2021-09-30 |
Inhibitors of protease-activated receptor-2 Grant 10,995,072 - Cumming , et al. May 4, 2 | 2021-05-04 |
Pharmaceutical Compounds App 20210101893 - Brown; Giles Albert ;   et al. | 2021-04-08 |
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor Grant 10,961,225 - Brown , et al. March 30, 2 | 2021-03-30 |
Pharmaceutical Compounds App 20210040067 - Brown; Giles Albert ;   et al. | 2021-02-11 |
Pharmaceutical Compounds App 20210002271 - Brown; Giles Albert ;   et al. | 2021-01-07 |
Pharmaceutical compounds Grant 10,858,352 - Brown , et al. December 8, 2 | 2020-12-08 |
Muscarinic Agonists App 20200354339 - Brown; Giles Albert ;   et al. | 2020-11-12 |
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor App 20200325118 - Brown; Giles Albert ;   et al. | 2020-10-15 |
Pharmaceutical compounds Grant 10,787,447 - Brown , et al. September 29, 2 | 2020-09-29 |
Pharmaceutical compounds Grant 10,752,610 - Brown , et al. A | 2020-08-25 |
Muscarinic agonists Grant 10,738,029 - Brown , et al. A | 2020-08-11 |
Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor Grant 10,689,368 - Brown , et al. | 2020-06-23 |
Inhibitors Of Protease-activated Receptor-2 App 20200140392 - Cumming; John Graham ;   et al. | 2020-05-07 |
Inhibitors of protease-activated receptor-2 Grant 10,550,089 - Cumming , et al. Fe | 2020-02-04 |
Pharmaceutical Compounds App 20200002328 - Brown; Giles Albert ;   et al. | 2020-01-02 |
Pharmaceutical Compounds App 20190389849 - Brown; Giles Albert ;   et al. | 2019-12-26 |
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor App 20190337925 - Brown; Giles Albert ;   et al. | 2019-11-07 |
Pharmaceutical Compounds App 20190276437 - Brown; Giles Albert ;   et al. | 2019-09-12 |
Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonists Grant 10,385,039 - Brown , et al. A | 2019-08-20 |
Pharmaceutical compounds Grant 10,329,278 - Brown , et al. | 2019-06-25 |
Inhibitors Of Protease-activated Receptor-2 App 20190144394 - Cumming; John Graham ;   et al. | 2019-05-16 |
Bicyclic Aza Compounds As Muscarnic M1 Receptor And/or M4 Receptor Antagonists App 20190112294 - Brown; Giles Albert ;   et al. | 2019-04-18 |
Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists Grant 10,196,380 - Brown , et al. Fe | 2019-02-05 |
Pharmaceutical Compounds App 20180362507 - Brown; Giles Albert ;   et al. | 2018-12-20 |
Muscarinic Agonists App 20180222885 - Brown; Giles Albert ;   et al. | 2018-08-09 |
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor Agonists App 20180179184 - Brown; Giles Albert ;   et al. | 2018-06-28 |
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists Grant 9,926,297 - Brown , et al. March 27, 2 | 2018-03-27 |
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor Agonists App 20170240530 - Brown; Giles Albert ;   et al. | 2017-08-24 |
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists Grant 9,670,183 - Brown , et al. June 6, 2 | 2017-06-06 |
Compouds App 20120322788 - Alcaraz; Lilian ;   et al. | 2012-12-20 |
Compounds App 20090298807 - Alcaraz; Lilian ;   et al. | 2009-12-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.